Three-Year Data of Zenflow's Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH

Three-Year Data of Zenflow's Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH

SOUTH SAN FRANCISCO, Calif., April 26, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the results of long-term data demonstrating that the investigational Zenflow Spring® System offers significant and durable benefits three years after placement. The Zenflow Spring is leading the way in establishing a new category of treatment, First-Line Interventional Therapy or "FIT", for patients suffering from benign prostatic hyperplasia (BPH) or e…

Dealing with prostate enlargement - The Okanagan Naturopath

Prostate enlargement is an abnormal enlargement of the prostate gland causing variable degrees of bladder outlet obstruction. Benign prostate hyperplasia, or BPH, is estimated to affect 50% of men over the age of 50 years. Eighty percent of men 80 years old or older are affected by BPH. The prost...

ClarityDX Prostate Utility Trial Enrolls First Patient

The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, biopsy reduction, and healthcare efficiency.